FourWorld Capital Management LLC 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
FourWorld Capital Management LLC disclosed 21 US equity positions worth $41.3m in its Q3 2025 13F filing. The largest position was EVLV at 17.3% of the reported book, followed by SRG and ABUS. Against the Q2 2025 filing, it opened 6 new positions, added to 5 and reduced 4 among the top 21 holdings.
What did FourWorld Capital Management LLC own in Q3 2025? Top 21 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | EVLV EVOLV TECHNOLOGIES HLDNGS IN | 17.3% | $7.1m | 944,902 | -41% | reduced | |
| 2 | SRG SERITAGE GROWTH PPTYS | 11.5% | $4.7m | 1,113,243 | 0% | held | |
| 3 | ABUS ARBUTUS BIOPHARMA CORP | Healthcare | 11.2% | $4.6m | 1,020,910 | -17% | reduced |
| 4 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 10.9% | $4.5m | 100,000 | 0% | held |
| 5 | AIRS AIRSCULPT TECHNOLOGIES INC | 7.6% | $3.1m | 391,156 | 2% | added | |
| 6 | XGN EXAGEN INC | 6.0% | $2.5m | 227,000 | 9% | added | |
| 7 | TASK TASKUS INC | Technology | 4.3% | $1.8m | 100,000 | 0% | held |
| 8 | SLDP SOLID POWER INC | 4.0% | $1.7m | 477,129 | 0% | held | |
| 9 | STIM NEURONETICS INC | Healthcare | 3.8% | $1.6m | 568,000 | 14% | added |
| 10 | ZKN ZEEKR INTELLIGENT TECHNOLOGY | 3.7% | $1.5m | 49,789 | -42% | reduced | |
| 11 | STLN THE ONCOLOGY INSTITUTE INC | 3.0% | $1.2m | 358,000 | -9% | reduced | |
| 12 | CVRX CVRX INC | 2.8% | $1.2m | 145,000 | 17% | added | |
| 13 | ESOA ENERGY SVCS ACQUISITION CORP | 2.8% | $1.2m | 112,357 | 39% | added | |
| 14 | DAR DARLING INGREDIENTS INC | Consumer Defensive | 2.5% | $1.0m | 34,000 | – | new |
| 15 | KSPI KASPI KZ JSC | 2.0% | $816.8k | 10,000 | 0% | held | |
| 16 | WW INTL INC | 1.9% | $797.5k | 29,150 | – | new | |
| 17 | BSM BLACK STONE MINERALS L P | 1.6% | $653.2k | 49,714 | – | new | |
| 18 | CMBT CMB.TECH NV | Energy | 1.2% | $503.4k | 53,607 | – | new |
| 19 | MOBILICOM LTD | 1.2% | $476.3k | 51,211 | – | new | |
| 20 | CDZI CADIZ INC | 0.4% | $151.2k | 32,043 | – | new | |
| 21 | TEVOGEN BIO HLDGS INC | 0.2% | $79.8k | 1,450,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.